1. United States of America Stocks

  2. •

    Financial Services

  3. •

    Shell Companies
Ibere Pharmaceuticals

Ibere Pharmaceuticals

IBER-UN
Ibere PharmaceuticalsUS flagNew York Stock Exchange
10.16
USD
- -
- -
Ibere Pharmaceuticals
IBER-UN
(New York Stock Exchange)

Recent

price

10.16

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Similar Companies
China Dongsheng International, Inc. (CDSG)
Worldwide NFT Inc. (WNFTD)
Emo Capital Corp. (NUVID)
Daedalus Special Acquisition Corp. (DSACW)
AlphaTime Acquisition Corp (ATMCW)
GX Acquisition Corp. (GXGXU)
Business
Ibere Pharmaceuticals Ibere Pharmaceuticals (IBER-UN) is a blank check company with no significant current operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities, particularly targeting opportunities in the pharmaceutical sector. Incorporated in 2020 as a Cayman Islands exempted company and headquartered in Philadelphia, Pennsylvania, the company completed its initial public offering of $138,000,000 in 2021 to fund its pursuit of a business combination.